Jaguar Health Files 8-K: Shareholder Vote & Financials
Ticker: JAGX · Form: 8-K · Filed: Mar 13, 2025 · CIK: 1585608
Sentiment: neutral
Topics: 8-K, shareholder-vote, financials
Related Tickers: JAGX
TL;DR
Jaguar Health filed an 8-K for shareholder votes and financials - details to come.
AI Summary
On March 13, 2025, Jaguar Health, Inc. filed an 8-K report detailing a submission of matters to a vote of security holders, a Regulation FD disclosure, and financial statements and exhibits. The filing does not contain specific financial figures or details about the matters to be voted on.
Why It Matters
This filing indicates upcoming shareholder decisions and the release of financial information, which could impact the company's strategic direction and investor outlook.
Risk Assessment
Risk Level: low — The filing is procedural and does not contain new material financial information or significant corporate events that would immediately impact risk.
Key Players & Entities
- Jaguar Health, Inc. (company) — Registrant
- March 13, 2025 (date) — Filing date
FAQ
What specific matters will be submitted for a vote of Jaguar Health's security holders?
The filing states that matters will be submitted to a vote of security holders, but does not specify what those matters are.
Are there any significant financial updates or results disclosed in this 8-K?
The filing indicates that financial statements and exhibits are included, but the provided text does not detail specific financial results or figures.
What is the purpose of the Regulation FD Disclosure mentioned in the filing?
The filing lists Regulation FD Disclosure as an item, suggesting that the company is ensuring fair disclosure of material information to all investors, but the specific content of the disclosure is not provided in the excerpt.
When was Jaguar Health, Inc. incorporated and in which state?
Jaguar Health, Inc. was incorporated in Delaware.
What is the principal executive office address for Jaguar Health, Inc.?
The principal executive offices are located at 200 Pine Street Suite 400, San Francisco, California, 94104.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 13, 2025 regarding Jaguar Health, Inc. (JAGX).